Ortivus is granted market approval of MobiMed in New Zealand.

Ortivus is now permitted to advertise and sell MobiMed in the New Zealand market.

We are happy to announce that all registration processes with the New Zealand Medical Device Authority, MedSafe are now completed. MobiMed is thereby notified on Medsafe’s Web Assisted Notification of Devices (WAND) database and Ortivus can now offer MobiMed to New Zealand’s prehospital care. 
”Pre-hospital healthcare in New Zealand has many similarities with the UK, where we have been successful for many years. We are looking forward to working together with our partner, Trapeze to deliver sustainable solutions that will improve patient care outcomes.” Magnus Mårtensson, Chief Product Officer, Ortivus